Dr. Bijan Salehizadeh serves as Managing Director at NaviMed Capital. He is a Board Member of Auris. He also serves as Advisor and Member of the Investment Committee at Waterline Ventures. He also serves as Board Member at Velocity Clinical Research. He is also the Board Member at CenterPointe Hospital. He spent several years in marketing and strategic planning at Medtronic Vascular, a world leader in medical technology. Before Medtronic, he was the Director of Business Development for HealthCentral, a venture-backed start-up that went public in 1999. During his medical training, he conducted research in minimally invasive heart valves and left ventricular assist devices and his work was published in several peer-reviewed scientific journals. He also served as a researcher at the National Heart, Lung and Blood Institute where he investigated coronary artery disease. He holds an A.B. in Molecular Biology from Princeton University, a M.S. in Health Policy from Columbia University, a M.D. in Medicine from Columbia University and an M.B.A. from Harvard Business School. He has also previously served as a member of the Kauffman Fellows program. He also serves as the Board member at Hyperion Therapeutics.